Literature DB >> 18680153

Bordetella holmesii bacteremia in sickle cell disease.

Timothy L McCavit1, Steve Grube, Paula Revell, Charles T Quinn.   

Abstract

Patients with sickle cell disease (SCD) have an increased risk of invasive bacterial infection because of hyposplenism. Bordetella holmesii is a recently described Gram-negative coccobacillus with an apparent predilection for asplenic hosts. We report two patients with SCD and B. holmesii bacteremia. Fastidious growth in culture and a typically uncomplicated clinical course distinguish B. holmesii infection from other invasive bacterial infections in SCD. Providers for patients with SCD should be aware of this pathogen and ensure that their microbiology laboratories are capable of isolating and identifying this organism.

Entities:  

Mesh:

Year:  2008        PMID: 18680153      PMCID: PMC4251868          DOI: 10.1002/pbc.21712

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  11 in total

1.  Severe Bordetella holmesii infection in a previously healthy adolescent confirmed by gene sequence analysis.

Authors:  F M Russell; J M Davis; M J Whipp; P H Janssen; P B Ward; J R Vyas; M Starr; S M Sawyer; N Curtis
Journal:  Clin Infect Dis       Date:  2001-06-05       Impact factor: 9.079

2.  Time to detection of positive BacT/Alert blood cultures and lack of need for routine subculture of 5- to 7-day negative cultures.

Authors:  D J Hardy; B B Hulbert; P C Migneault
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

3.  Community-acquired pneumonia due to Bordetella holmesii in a patient with frequently relapsing nephrotic syndrome.

Authors:  Christina Dörbecker; Christoph Licht; Friederike Körber; Georg Plum; Christiane Haefs; Bernd Hoppe; Harald Seifert
Journal:  J Infect       Date:  2006-12-14       Impact factor: 6.072

4.  Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.

Authors:  M H Gaston; J I Verter; G Woods; C Pegelow; J Kelleher; G Presbury; H Zarkowsky; E Vichinsky; R Iyer; J S Lobel
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

5.  Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates.

Authors:  E Njamkepo; F Delisle; I Hagege; G Gerbaud; N Guiso
Journal:  Clin Microbiol Infect       Date:  2000-03       Impact factor: 8.067

6.  Bordetella holmesii-like organisms associated with septicemia, endocarditis, and respiratory failure.

Authors:  Y W Tang; M K Hopkins; C P Kolbert; P A Hartley; P J Severance; D H Persing
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

7.  Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

Authors:  Natasha B Halasa; Sadhna M Shankar; Thomas R Talbot; Patrick G Arbogast; Ed F Mitchel; Winfred C Wang; William Schaffner; Allen S Craig; Marie R Griffin
Journal:  Clin Infect Dis       Date:  2007-04-18       Impact factor: 9.079

8.  Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia.

Authors:  R S Weyant; D G Hollis; R E Weaver; M F Amin; A G Steigerwalt; S P O'Connor; A M Whitney; M I Daneshvar; C W Moss; D J Brenner
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

9.  Positive blood cultures in sickle cell disease: time to positivity and clinical outcome.

Authors:  Cynthia F Norris; Kim Smith-Whitley; Karin L McGowan
Journal:  J Pediatr Hematol Oncol       Date:  2003-05       Impact factor: 1.289

10.  Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients.

Authors:  Colin W Shepard; Maryam I Daneshvar; Robyn M Kaiser; David A Ashford; David Lonsway; Jean B Patel; Roger E Morey; Jean G Jordan; Robbin S Weyant; Marc Fischer
Journal:  Clin Infect Dis       Date:  2004-03-01       Impact factor: 9.079

View more
  7 in total

1.  First report of infectious pericarditis due to Bordetella holmesii in an adult patient with malignant lymphoma.

Authors:  Takahito Nei; Hideya Hyodo; Kazunari Sonobe; Kazuo Dan; Ryoichi Saito
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

Review 2.  Resemblance and divergence: the "new" members of the genus Bordetella.

Authors:  Roy Gross; Kristina Keidel; Karin Schmitt
Journal:  Med Microbiol Immunol       Date:  2010-08       Impact factor: 3.402

3.  Bordetella holmesii: initial genomic analysis of an emerging opportunist.

Authors:  Paul J Planet; Apurva Narechania; Saul R Hymes; Christina Gagliardo; Richard C Huard; Susan Whittier; Phyllis Della-Latta; Adam J Ratner
Journal:  Pathog Dis       Date:  2013-02-26       Impact factor: 3.166

4.  Bordetella holmesii bacteremia in asplenic children: report of four cases initially misidentified as Acinetobacter lwoffii.

Authors:  Markos Ioannis Panagopoulos; Maude Saint Jean; Delphine Brun; Nicole Guiso; Sadjia Bekal; Philippe Ovetchkine; Bruce Tapiero
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

5.  Bordetella holmesii bacteremia cases in the United States, April 2010-January 2011.

Authors:  Sara Y Tartof; Prabhu Gounder; Don Weiss; Lillian Lee; Pamela K Cassiday; Thomas A Clark; Elizabeth C Briere
Journal:  Clin Infect Dis       Date:  2013-10-02       Impact factor: 9.079

6.  A real-time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence and distribution of three Insertion Sequence elements.

Authors:  Lieuwe Roorda; Johannes Buitenwerf; Jacobus M Ossewaarde; Anneke van der Zee
Journal:  BMC Res Notes       Date:  2011-01-21

7.  Lack of cross-protection against Bordetella holmesii after pertussis vaccination.

Authors:  Xuqing Zhang; Laura S Weyrich; Jennie S Lavine; Alexia T Karanikas; Eric T Harvill
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.